Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
The Ranger Road Fire spreads from the Oklahoma Panhandle into Kansas as high winds and red flag conditions persist
President Donald Trump signed an executive order this week to accelerate domestic production of phosphorus and glyphosate, signaling that farm input availability is now treated as a national security risk.
Fred Nichols, Chief Sales and Marketing Officer for Huma, joined us with a sneak peek at Commodity Classic next week in San Antonio, Texas.
RFD NEWS Markets Specialist Tony St. James reviews the USDA’s Farms and Land in Farms 2025 Summary.
Biofuel and corn producers await proposal as Renewable Fuels Association pushes for expanded ethanol access.
Coverage on “Market Day Report,” Wed, 2/25 – Fri, 2/27, 2026
